Style | Citing Format |
---|---|
MLA | Iraji F, et al.. "Cutaneous Leukocytoclastic Vasculitis Secondary to Covid-19 Infection: A Case Report." Clinical Case Reports, vol. 9, no. 2, 2021, pp. 830-834. |
APA | Iraji F, Galehdari H, Siadat AH, Bokaei Jazi S (2021). Cutaneous Leukocytoclastic Vasculitis Secondary to Covid-19 Infection: A Case Report. Clinical Case Reports, 9(2), 830-834. |
Chicago | Iraji F, Galehdari H, Siadat AH, Bokaei Jazi S. "Cutaneous Leukocytoclastic Vasculitis Secondary to Covid-19 Infection: A Case Report." Clinical Case Reports 9, no. 2 (2021): 830-834. |
Harvard | Iraji F et al. (2021) 'Cutaneous Leukocytoclastic Vasculitis Secondary to Covid-19 Infection: A Case Report', Clinical Case Reports, 9(2), pp. 830-834. |
Vancouver | Iraji F, Galehdari H, Siadat AH, Bokaei Jazi S. Cutaneous Leukocytoclastic Vasculitis Secondary to Covid-19 Infection: A Case Report. Clinical Case Reports. 2021;9(2):830-834. |
BibTex | @article{ author = {Iraji F and Galehdari H and Siadat AH and Bokaei Jazi S}, title = {Cutaneous Leukocytoclastic Vasculitis Secondary to Covid-19 Infection: A Case Report}, journal = {Clinical Case Reports}, volume = {9}, number = {2}, pages = {830-834}, year = {2021} } |
RIS | TY - JOUR AU - Iraji F AU - Galehdari H AU - Siadat AH AU - Bokaei Jazi S TI - Cutaneous Leukocytoclastic Vasculitis Secondary to Covid-19 Infection: A Case Report JO - Clinical Case Reports VL - 9 IS - 2 SP - 830 EP - 834 PY - 2021 ER - |